Red near infrared light therapy in Motor neurone disease (MND)

Professor Paul Chazot, WRIHW Fellow, has been working on Photobiomodulation therapy (PBMT) for over 20 years, and was the first to explore and validate the use of the brain penetrating 1070nm wavelength for use in neurodegenerative diseases. Clinical validation in Alzheimers, Parkinsons and Covid brain fog in the US, has followed in the last few years. A UK trial is currently in preparation. We're thrilled to share the incredible journey of Seb Bousie, who was diagnosed for motor neuron disease 8 years ago.. Seb has been using the CERA Thrive PBMT System for 6 months, and in combination with a healthy diet and a supplement regimen, he has experienced a remarkable transformation in his health. After being in a wheelchair for over 4 years, Seb is now able to stand and even take a few steps. He also describes improvement in his brain fog and general health and wellbeing. This amazing progress is a testament to his commitment and the effectiveness of red light therapy to support overall wellness. Seb followed a protocol of infrared light therapy 4-5 times per week, with the CERA headband and body panel (based on a unique brain-microbiome rationale). The device uses a mixture of useful evidence-based infrared wavelengths, including, importantly, in the headband device, our favourite 1070nm wavelength.

You can view the video here. https://x.com/cerathrive/status/1806048974522175716